Pharvaris N.V. Files June 2025 6-K Report

TL;DR

Pharvaris N.V. (PHVS) filed a 6-K for June 2025, confirming 20-F reporting and Dutch HQ.

AI Summary

Pharvaris N.V. filed a Form 6-K on June 10, 2025, to report information for the month of June 2025. The filing indicates that Pharvaris N.V. is a foreign private issuer and will file annual reports under Form 20-F. The company is located in Leiden, The Netherlands, and its principal executive office is at Emmy Noetherweg 2, 2333 BK Leiden.

Why It Matters

This filing provides routine updates for investors and regulatory bodies regarding Pharvaris N.V.'s status as a foreign private issuer and its reporting obligations.

Risk Assessment

Risk Level: low — This filing is a routine disclosure and does not contain new material financial or operational information that would typically increase risk.

Key Players & Entities

• Pharvaris N.V. (company) — Filer of the 6-K report
• June 2025 (date) — Reporting period for the 6-K
• Form 20-F (document) — Annual report form to be filed by the company
• Leiden, The Netherlands (location) — Location of the company's principal executive office

FAQ

From the Filing

0000950170-25-084094.txt : 20250610 0000950170-25-084094.hdr.sgml : 20250610 20250610065208 ACCESSION NUMBER: 0000950170-25-084094 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 28 CONFORMED PERIOD OF REPORT: 20250610 FILED AS OF DATE: 20250610 DATE AS OF CHANGE: 20250610 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pharvaris N.V. CENTRAL INDEX KEY: 0001830487 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40010 FILM NUMBER: 251035910 BUSINESS ADDRESS: STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN STATE: P7 ZIP: 00000 BUSINESS PHONE: 31 (0)71 203 6410 MAIL ADDRESS: STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN STATE: P7 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: Pharvaris, B.V. DATE OF NAME CHANGE: 20201029 6-K 1 6-k_agm_pr_announcement_.htm 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of June 2025 Commission File Number: 001-40010 Pharvaris N.V. (Translation of registrant’s name into English) Emmy Noetherweg 2   2333 BK Leiden   The Netherlands (Address of principal executive office)   Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐   Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐   Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR. PHARVARIS N.V.     On June 10, 2025, Pharvaris N.V. (the “Company”) issued a press release announcing its 2025 annual general meeting of shareholders to be held on June 27, 2025 and made available to its shareholders certain other materials in connection with such meeting. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein. The materials made available to the Company’s shareholders are attached as Exhibits 99.2 and 99.3 hereto and are incorporated by reference herein. Exhibit 99.4 contains the Company’s Annual Report for the year ended December 31, 2024, which is furnished herewith.         SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.   PHARVARIS N.V.     Date: June 10, 2025 By: /s/ Berndt Modig   Name: Berndt Modig   Title: Chief Executive Officer   EXHIBIT INDEX   Exhibit No.   Description       99.1   Press Release dated June 10, 2025. 99